Patent directory · USPTO A61K / A61P
Patents matching “The Board of Regents of the University of Texas System”
1,742 pharma patents match "The Board of Regents of the University of Texas System" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 1,742 pharmaceutical patents matching "The Board of Regents of the University of Texas System" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 11696950
Dry solid aluminum adjuvant-containing vaccines and related methods thereof
granted -
US 11696933
HLA-restricted VCX/Y peptides and T cell receptors and use thereof
granted -
US 11692027
Antibody and protein therapeutic formulations and uses thereof
granted -
US 11690851
Methods and compositions comprising ursolic acid and/or resveratrol for treating diabetes, or cancer
granted -
US 11690919
Endolysosomal targeting conjugates for improved delivery of cargo molecules to the endolysosomal compartment of target cells
granted -
US 11690850
Inhibitors of receptor interacting protein kinase I for the treatment of disease
granted -
US 11690825
20-HETE receptor (GPR75) antagonists and methods of use
granted -
US 11684657
HLA-restricted VGLL1 peptides and use thereof in promoting an immune response in a subject
granted -
US 11685710
Cationic sulfonamide amino lipids and amphiphilic zwitterionic amino lipids
granted -
US 11684626
Methods and compositions comprising ursolic acid and/or resveratrol for treating obesity, diabetes, or cancer
granted -
US 11680067
Small molecules for the treatment of primary cancer and cancer metastasis
granted -
US 11673966
Monoclonal and humanized antibodies to a cancer glycopeptide
granted -
US 11673867
Sulfonamide derivative or pharmaceutically acceptable acid-addition salt
granted -
US 11666634
Methods and compositions for management of gastrointestinal disorders
granted -
US 11660352
Dual function antibodies specific to glycosylated PD-L1 and methods of use thereof
granted -
US 11660325
Compositions and methods of targeting cancer stem cells
granted -
US 11648297
Bioresponsive particles
granted -
US 11648210
Compositions and methods for organ specific delivery of nucleic acids
granted -
US 11648209
Compositions and methods for organ specific delivery of nucleic acids
granted -
US 11648272
Human kynureninase enzymes and uses thereof
granted -
US 11648307
Anti-DC-HIL antibodies for cancer diagnosis, prognosis and therapy
granted -
US 11642849
In vivo live 3D printing of regenerative bone healing scaffolds for rapid fracture healing
granted -
US 11642335
Chemical synthesis of clopidogrel active metabolites and disulfide conjugate prodrugs
granted -
US 11643640
Rift valley fever vaccine
granted